Business Wire

NJ-OPEX

11.3.2024 15:01:27 CET | Business Wire | Press release

Share
Meet the Next Generation of Automated Sortation and Order Retrieval―Introducing OPEX® Sure Sort® X with OPEX Xtract™

OPEX® Corporation, a global leader in Next Generation Automation for almost 50 years, today announced the launch of its newest automated sorting and order retrieval solutions―OPEX Sure Sort® X with OPEX Xtract™. These innovative technologies were officially unveiled by company leadership at MODEX 2024, the largest manufacturing and supply chain trade event, held this year at the Georgia World Congress Center in Atlanta.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240311187962/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

OPEX® Sure Sort® X with OPEX Xtract™ (Photo: Business Wire)

OPEX Sure Sort X represents the next generation of high-speed, automated sorting. It is the most robust industrial sorting solution available in the market, unmatched in terms of its compact footprint, performance rates, and cost-effectiveness. This universal system can handle nearly 100% of customer-sortable items weighing up to 20 pounds (9 kg), and sort items into a configurable array of mixed bin sizes and types.

When Sure Sort X is paired with Xtract―OPEX’s revolutionary new automated order retrieval system―the task of retrieving totes and transferring their contents into shipping containers is now fully automated, as well. The result is a one-touch solution that can eliminate the need to manually sort and transfer boxes downstream.

"OPEX remains dedicated to innovations that align with the evolving demands of the market," stated Alex Stevens, President of Warehouse Automation at OPEX. "We have received feedback from our customers that they want one integrated solution to sort, retrieve, and automatically get the product into its final container. Our new solutions, Sure Sort X and Xtract, are a response to those requests. This cutting-edge technology is designed to automate multiple manual tasks with a simple, one-touch solution.”

Developed based on feedback from the international business community, Sure Sort X applies OPEX Corporation’s innovative, industry-leading Sure Sort technology, introduced in 2017. With its enhanced product handling capabilities, Sure Sort X is the single most versatile and configurable sorting solution available. It can handle items 60 percent smaller, nearly 20 percent larger, and up to 300 percent heavier than its predecessor, all while maintaining a consistent throughput of up to 2,100 items per hour.

The system’s iBOT® delivery vehicles utilize sophisticated motion algorithms that allow them to maneuver throughout the system efficiently, with the ability to change destination in real time while in transit. These iBOTs can drive in and out of the system while Sure Sort X continues to run, ensuring the highest level of uptime and availability. In addition, Sure Sort X can operate in both chilled and ambient environments. Installation can occur in as little as one week.

OPEX Xtract can be added to any Sure Sort X system by introducing retrieval iBOTs to work in conjunction with the traditional sortation iBOTs found in Sure Sort X. Xtract iBOTs move in a loop that has both horizontal and vertical segments within the Sure Sort X aisle, and can handle up to 200 extracted totes per hour. All of the iBOTs are self-charging and can easily be added to or removed from the system.

The system can retrieve standard totes or can be outfitted with Xtract totes, which are uniquely designed to transport items from the sort location to any available roller, v-chute, transfer (RVT) module. If these totes are used, once all products for a relevant order have been deposited into the Xtract totes, each tote is retrieved and transported to the RVT module, where the tote door opens and releases the items into the final shipping box or order container.

Soon after its unveiling in the US at MODEX, Sure Sort X will make its European debut at the LogiMAT expo in Stuttgart, Germany, on March 19, 2024, at the OPEX exhibit in Hall 7, Stand 7D53.

Sure Sort X and Xtract join the existing Warehouse Automation portfolio at OPEX, which includes Sure Sort®—the industry-leading, high-speed, small-item robotic sorting system; Perfect Pick®, a robotic goods-to-person picking solution that dramatically improves speed, efficiency, and reliability, and Infinity®―the most advanced goods-to-person solution available in warehouse automation. All are custom configured for each client and designed to completely transform supply chain infrastructure.

For nearly five decades, OPEX Corporation has served as a trusted partner, collaborating closely with clients to develop customized, scalable solutions that transform how business is conducted. OPEX continuously reimagines automation technology to help clients solve their most significant business challenges, today and in the future.

About OPEX

OPEX® Corporation is a global leader in Next Generation Automation, providing innovative, unique solutions for warehouse, document and mail automation. With headquarters in Moorestown, NJ, USA—and facilities in Pennsauken, NJ; Plano, TX; France; Germany; Switzerland; the United Kingdom; and Australia—OPEX has more than 1,600 employees who are continuously reimagining and delivering customized, scalable technology solutions that solve the business challenges of today and in the future.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240311187962/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye